Shuo Yang, Yibing Hou, Xiaohui Wang, Shuo Kang, Zhenhua Pan. "Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis." PLoS ONE, 2026. doi:10.1371/journal.pone.0351029